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Abstract: New approaches to deal with the growing concern associated with antibiotic-resistant
bacteria are emerging daily. Essential oils (EOs) are natural antimicrobial substances with great
potential to mitigate this situation. However, their volatile nature, in their liquid-free form, has
restricted their generalized application in biomedicine. Here, we propose the use of cellulose acetate
(CA)/polycaprolactone (PCL) wet-spun fibers as potential delivery platforms of selected EOs to fight
infections caused by Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Twenty EOs were
selected and screened for their minimal inhibitory concentration (MIC), using the antibiotic ampicillin
as positive control. The cinnamon leaf oil (CLO), cajeput oil (CJO), and the clove oil (CO) were the
most effective EOs, against the Gram-positive (MIC < 22.38 mg/mL) and the Gram-negative (MIC
< 11.19 mg/mL) bacteria. Uniform microfibers were successfully wet-spun from CA/PCL with an
averaged diameter of 53.9 ± 4.5 µm, and then modified by immersion with CLO, CJO and CO at
2 ×MIC value. EOs incorporation was confirmed by UV-visible spectroscopy, Fourier-transformed
infrared spectroscopy, and thermal gravimetric analysis. However, while microfibers contained
ampicillin at MIC (control) after the 72 h modification, the CLO, CO and CJO-loaded fibers registered
≈ 14%, 66%, and 76% of their MIC value, respectively. Data showed that even at small amounts
the EO-modified microfibers were effective against the tested bacteria, both by killing bacteria more
quickly or by disrupting more easily their cytoplasmic membrane than ampicillin. Considering the
amount immobilized, CLO-modified fibers were deemed the most effective from the EOs group.
These results indicate that CA/PCL microfibers loaded with EOs can be easily produced with increased
antibacterial action, envisioning their use as scaffolding materials for the treatment of infections.
Keywords: cinnamon leaf oil; cajeput oil; clove oil; antibacterial properties; microfibers immobilization
1. Introduction
For many years, biomolecules have been used in biomedical applications to fight infections
and/or instigate specific cell/tissue responses. A wide range of antimicrobial agents fall within the
category of biomolecules, including the antibiotics, peptides, enzymes, organic nanoparticles, and
natural extracts [1]. From those, the most widely used are the antibiotics. However, their excessive
consumption and misuse have accelerated the rise of antibiotic-resistant microorganisms, which,
nowadays, constitute one of the dominant challenges to global health [2]. In fact, recent projections
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indicate that bacterial infections may be the cause of approximately 10 million annual deaths worldwide
by 2050, a number considerably superior to current cancer statistics [3]. Therefore, alternative strategies
to antibiotics are in urgent need to treat infections. Natural products derived from plants with
antimicrobial, anti-inflammatory, antioxidant, and chemo-preventive properties have been used for
many generations in traditional medicine [4]. Nowadays, they are gaining new status as an alternative
to antibiotics, by preventing and treating infectious diseases with little impact in the environment [5].
Essential oils (EOs) are mixtures of aromatic, volatile, lipophilic biomolecules, extracted from regions
of plants (e.g., flowers, leaves, twigs, bark, wood, fruits, etc.) in which they work as secondary
metabolites, defending the host from microbial invasion [1,5]. They are formed of complex mixtures
of hydrophobic molecules, including thymol, carvacrol, and eugenol (among others), which exhibit
a broad spectrum of antimicrobial activity against bacteria, fungi, and viruses. Research has also
demonstrated the EOs potential to replace antibiotics due to their inherent and strong anti-inflammatory,
antiseptic, analgesic, spasmolytic, anesthetic, and antioxidative properties [6]. Still their cytotoxicity at
increased concentrations, their low resistance to degradation by external factors (e.g., temperature,
light, moisture), and their volatility in their free, liquid form remain difficult challenges to overcome
for their expanded use. Here, fibers and fibrous constructs have emerged as optional platforms for
their targeted and therapeutic delivery, this way promoting their application in the combat against
drug-resistant bacteria [7,8].
The wet-spinning technique is a nonsolvent induced phase inversion approach that allows the
production of continuous polymeric microfibers, with uniform morphology, by injecting a polymer
solution into a nonsolvent coagulation bath that prompts the solidification of the extruded material [7,9].
This technique has been raising attention in the biomedical field for its simple set-up, enabling the
production of fibers at the microscale for controlled drug release and/or tissue engineering applications.
Further, wet-spinning allows 3D constructs to be formed with an intricate fibrous network that facilitates
cell infiltration within the scaffold’s inner regions, something that is limited in electrospun nanofibrous
meshes due to their small pore sizes and high fiber packing density [10]. This technique was originally
introduced in biomedicine to process natural polymers, such as chitosan, collagen, or silk fibroin,
which were susceptible to degradation when subjected to other conventional spinning techniques or
very difficult to establish optimal processing parameters via electrospinning [11]. The possibility of
easily loading wet-spun fibers with a wide range of therapeutic agents has been very important to
broaden its use to synthetic polymers [12].
In this study, we propose the production of cellulose acetate (CA) and polycaprolactone (PCL)
microfibers loaded with selected EOs for potential applications in the biomedical field. CA is the
acetate ester of cellulose and one of its most common derivatives. CA is a bio-based polymer,
endowed with a unique nanostructure and remarkable physicochemical properties, is biocompatible
and biodegradable, and can be efficiently processed into membranes, films, and fibers [13–16]. It is
also capable of high entrapment efficiency and, consequent, delivery of diverse therapeutic drugs.
Furthermore, it has been shown that these properties can be enhanced by blending it with other
polymers, such as PCL [17]. This synthetic polymer displays excellent mechanical performance,
miscibility with other polymer solutions, and is also biocompatible and biodegradable [18]. To the
authors’ knowledge, this is the first report on the effect of EOs on the physical, thermal, and antimicrobial
properties of CA/PCL microfibers, processed by wet-spinning. Here, various EOs were examined
and the most effective against Gram-positive and Gram-negative bacteria were immobilized onto the
biodegradable microfibers and further explored for their effects on the fiber’s physical, thermal, and
antimicrobial properties.
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2. Materials and Methods
2.1. Materials
EOs were purchased from Folha d’Água Company (Portugal) and are listed in Table 1. Trypticase
soy broth (TSB) and trypticase soy agar (TSA) were acquired from VWR, while Mueller Hinton broth
(MHB) was obtained from CondaLab. Bacteria were supplied from American Type Culture Collection
(ATCC), encompassing Gram-positive bacteria, Staphylococcus aureus (S. aureus, ATCC 6538), and
Gram-negative bacteria, Escherichia coli (E. coli, ATCC 25922). The antibiotic ampicillin was purchased
from Sigma and used as positive control in all the experiments.
Table 1. List of tested essential oils (EOs)s, their origin, and density.
EO Abbreviation Origin Density (g/cm3)
Amyris AO Amyris balsamifera 0.957
Cajeput CJO Melaleuca leucadendron 0.911
Cinnamon leaf CLO Cinnamomum zeylanicum 1.049
Citronella CIO Cymbopogon winterianus 0.882
Clove CO Eugenia caryophyllus 1.056
Eucalyptus ELO Eucalyptus globulus L. 1.465
Frankincense FO Boswellia carterii 0.857
Geranium GO Pelargonium graveolens 0.895
Himalayan cedar HCO Cedrus deodara Loud. 0.935
Lavandin LO Lavandula hybrida 0.889
Lemongrass LGO Cymbopogon flexuosus 0.890
Niaouli NO Melaleuca viridiflora 0.913
Orchid OO Orchidaceae 0.856
Palmarosa PMO Cymbopogon martiniivar.motia 0.884
Patchouli PTO Pogostemon patchouli 0.960
Rosemary RO Rosmarinus officinalis 0.900
Sage SO Salvia officinalis 0.915
Star anise SAO Illicium verum 0.981
Tea tree oil TTO Melaleuca alternifolia 0.895
Wintergreen WO Gaultheria procumbens 1.182
Cellulose acetate (CA, Mn = 30,000 and 39.8 wt % acetyl content) and polycaprolactone (PCL,
Mn = 45,000) were purchased from Sigma and used in the production of wet-spun microfibers. Acetone
(Ace, Millipore) and glacial acetic acid (AA, Fisher Scientific) were used as polymer solvents, and
absolute ethanol (EtOH, Millipore) was employed as coagulation bath.
EOs were diluted in MHB at 40–0.078%, which corresponded to an average maximum concentration
of 385.442 ± 56.877 mg/mL and an average minimum concentration of 0.753 ± 0.111 mg/mL; maximum
and minimum concentrations for each oil were dependent on their inherent density (Table 1). Ampicillin
(A) was prepared in distilled water (dH2O) at concentrations 1000–1.95 µg/mL. For the purpose of this
work, fiber samples were labeled with an “F” prior to the name of the immobilized biomolecule.
2.2. Agar-Well Diffusion Assay
The EOs antibacterial activity was initially assessed visually against S. aureus and E. coli via the
Kirby-Bauer method. Briefly, bacteria inoculums were prepared in TSB and left to grow overnight
at 37 ◦C and 120 rpm. Then, their concentration was adjusted to 1.0 × 107 colony forming units
(CFUs)/mL and 1 mL was collected and combined with 14 mL of TSA warmed at approximately
45 ◦C. The 15 mL bacterial solution was poured into 90 mm diameter Petri dishes and left to solidify.
Sterilized punchers were used to generate 6 mm diameter holes on the agar. A 40 µL volume of each
antimicrobial agent, at the highest concentration studied (40%), were introduced in the respective
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holes. Plates were incubated at 37 ◦C for 24 h. Zones of inhibition (ZoI) were observed and measured
to confirm the EOs’ antibacterial efficacy.
2.3. Minimum Inhibitory Concentrations (MICs)
MICs were determined using the broth microdilution procedure described by Wiegand et al. [19],
which adapts the standard published by the Clinical and Laboratory Standards Institute (CLSI) and
the European Committee on Antimicrobial Susceptibility Testing (EUCAST) [20].
Working solutions were prepared as described in Section 2.1, and added to the first column of
96-well plates in a volume of 100µL. Serial dilutions (1:2) were made with MHB in the consecutive
wells, to a final volume of 50µL. Then, to each of these wells, 50µL of the bacteria suspensions prepared
at 1 × 107 CFUs/mL in MHB were added. Free bacteria suspensions and culture media were used as
controls. Absorbance readings at a wavelength of 600 nm (EZ READ 2000 Microplate Reader, Biochrom
Ltd., Cambridge, UK) were made before and after plate incubation for 24 h at 37 ◦C and 120 rpm.
The MIC value for each agent/bacteria combination was established as the concentration at which
bacteria did not show any growth, determined visually, and confirmed by the differences in absorbance
readings. The existence of viable cells at MIC and at concentrations in its vicinity (concentration
higher and lower than MIC value) was determined by measuring the number of CFU s/mL. Briefly,
aliquots of 10 µL of each cell suspension, diluted from 101 to 105 in phosphate buffer saline solution
(PBS), were cultured in TSA plates for 24 h at 37 ◦C, and colonies were counted. The three most
effective EOs against both bacteria (lowest MICs) were highlighted from the group and used in the
subsequent experiments.
2.4. Cell Wall Disruption: Scanning Electron Microscopy (SEM) Observations
To analyze the EOs capacity to interfere with the cell morphology of Gram-positive and
Gram-negative bacteria, visual studies resorting to SEM were conducted. Here, only the most
effective EO was selected since the mechanisms of action are very similar among EOs [5]. Bacteria
suspensions were prepared at 1 × 105 CFUs/mL in MHB and combined at 50% (v/v) with the selected
EO (cinnamon leaf oil (CLO)) at MIC value. A 500 µL volume of each solution (250 µL CLO + 250 µL
bacteria) were left in direct contact with 12-well tissue culture plates (TCPS) and incubated at 37 ◦C for
24 h at 120 rpm. Untreated bacteria were used as control. Afterwards, culture media was removed and
500 µL of 2.5% (v/v) glutaraldehyde in PBS were added to each sample for 1 h at room temperature
(RT), to promote cell fixation to the TCPS wells. Plates were gently rinsed with dH2O and submitted to
a dehydration process using serial ethanol dilutions, 55%, 70%, 80%, 90%, 95%, and 100% (v/v), each
solution was left in the TCPS for 30 min at RT, and then carefully discarded. After the last solution,
the remaining ethanol was evaporated at RT. Discs were cut from the TCPS wells, containing the
fixated and dehydrated bacteria, using a hot press-on apparatus and covered with a thin film (10 nm)
of Au-Pd (80–20 wt %) in a 208HR high-resolution sputter coater (Cressington Company, Watford,
UK) coupled to an MTM-20 Cressington high-resolution thickness controller. Cell morphology was
observed via FEG-SEM (NOVA 200 Nano SEM, FEI Company, Hillsboro, Oregon, USA), using an
electron accelerating voltage of 10 kV.
2.5. Wet-Spun Fiber Production and EO Immobilization
CA/PCL spinning solution was prepared by dissolving CA at 10% w/v in AA and PCL at 14%
w/v in 3:7 v/v Ace/AA. The ratio of blended polymer (CA/PCL) was 3:1 v/v. These concentrations and
ratios were selected based on previously published work [17]. The complete dissolution of polymers
was achieved under stirring at 90 ◦C, for 1 h (300 rpm), followed by overnight slow stirring (30 rpm) to
remove existing air bubbles. CA/PCL was then processed by wet-spinning (Figure S1). The set-up was
composed of a syringe pump (NE-1600, New Era Pump Systems, Norleq, Porto, Portugal) coupled to a
20 mL syringe and 18-gauge (G) needle. The polymer solution was extruded at a flow rate of 0.5 mL/h
within an EtOH coagulation bath, at ≈21.5 ◦C. The distance between the needle tip and the bottom of
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the coagulation bath was kept constant (≈3 cm). Microfibers were collected manually and stored in the
form of 21 cm length samples (ca. 0.5 mg) for subsequent testing.
Microfibers were divided into five groups: (1) unloaded (control) and loaded with (2) ampicillin
(positive control), (3) CLO, (4) CO, and (5) CJO. Fibers were immersed in an ethanol solution containing
each of the EOs at a concentration of 2 x MIC for 72 h at RT and 200 rpm, for immobilization. This period
was selected based on the control sample containing ampicillin, which reached maximum incorporation
(equivalent to MIC) at this moment, after measurements at 24 and 48 h being insufficient (data not
shown); longer periods would imply an excess of ampicillin at the fiber’s surface. Peaks of absorbance
(207–212 nm) were established for each oil by conducting calibration curves that related absorbance to
EOs concentration. The percentage of EO incorporated was determined by measuring the difference
of absorbance at times 0 and 72 h (UV–VIS 1800, Shimadzu, Shimadzu Schweiz GmbH, Reinach BL,
Switzerland). Any alterations in the absorbance of the control samples (unloaded) were considered
and subtracted from the final absorbance for each sample.
2.6. Fiber Characterization
2.6.1. Morphology: Brightfield Microscopy
Brightfield images of the microfibers morphology were collected using an inverted microscope
Leica DM IL LED (Leica Microsystems, Wetzlar, Germany), both in the absence and presence of
immobilized antimicrobial agents. After the 72 h immobilization process, samples were washed with
dH2O for 5 min (3 times), mounted with VECTASHIELD® Mounting Medium (Vector Laboratories,
Burlingame, California, USA) and sealed for observation. Images were captured with 10× and 40×
objectives, with the averaged fiber diameter being determined from 5 images collected for each sample
type and measured through ImageJ software (version 1.52a).
2.6.2. Chemical Composition: Attenuated Total Reflectance with Fourier-Transform Infrared
Spectroscopy (ATR-FTIR)
An IRAffinity-1S, SHIMADZU spectrophotometer (Kyoto, Japan), with an ATR accessory (diamond
crystal) was used to record the CA/PCL fibers ATR-FTIR spectra. For each fiber, a total of 45 scans
were performed at a spectral resolution of 8 cm−1, over the wavenumber range of 400–4000 cm−1.
2.6.3. Thermal Stability: Thermal Gravimetric Analysis (TGA)
TGA measurements were conducted on a STA 7200 Hitachi® (Fukuoka, Japan) using a platinum
pan. The TGA trace was obtained in the range of 25–600 ◦C under a dynamic nitrogen atmosphere,
flow rate of 200 mL/min and temperature rise of 10 ◦C/min. Results were plotted as a percentage of
mass loss vs. temperature and as weight loss rate vs. temperature (derivative thermogravimetric
curve, DTG).
2.7. Time-Kill Kinetics
Bacteria suspensions were prepared at 1 × 105 CFUs/mL in MHB and combined with the
antimicrobial agents at MIC percentage (according to the EOs loading efficiency results) or the modified
fibers. Control groups were prepared without the addition of any agent or by using unmodified fibers.
Bacteria-containing solutions were incubated at 37 ◦C and 120 rpm. After 0 (before action), 1, 2, 4, 6,
and 24 h of incubation, bacteria were serially diluted (101 to 105 in PBS), cultured on TSA plates, and
further incubated for another 24 h at 37 ◦C. Colonies of surviving bacteria were counted and reported
as mean ± standard deviation (S.D.). Log reduction determinations were also conducted between
bacteria solutions with and without antimicrobial agents and fibers unloaded and loaded and reported
as mean ± S.D. Data were collected in triplicate and processed using the GraphPad Prism 7.0 software.
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2.8. Membrane Permeability
The bacteria membrane permeability was evaluated by adapting the procedure described by
Kong et al. [21]. Differences in relative electric conductivities (REC) of bacteria suspensions by the
addition of antimicrobial agents can be used to determine their capacity to penetrate the membrane,
as conductance has been suggested as an indicator not only of pore size but also interaction of permeating
ions with wall channels in various bacteria [22]. Here, REC were measured after subculturing S. aureus
and E. coli bacteria in MHB overnight. Bacteria were collected by centrifugation at 5000 rpm for 10 min,
their concentration adjusted to 1 × 105 CFUs/mL, and then washed in a 5% glucose solution until
their electric conductivities were close to that of 5% glucose (isotonic bacteria). The EOs (at a loaded
concentration on microfibers) and microfibers (unloaded and loaded) were then added to the 5%
glucose solution and electric conductivities of the mixtures were marked as L1. Ampicillin, EOs, and
microfibers (unloaded and loaded) were added into the isotonic bacteria solution. After completely
mixed, the samples were incubated at 37 ◦C for 6 h, and their conductivities measured and marked
as L2. The control was the bacteria in 5% glucose treated in boiling water for 5 min, marked as L0.





Data were collected in triplicate and reported as mean ± S.D. using the GraphPad Prism
7.0 software.
3. Results and Discussion
3.1. Agar-Well Diffusion
EOs were initially screened for their antibacterial activity against the Gram-positive bacteria
S. aureus and the Gram-negative bacteria E. coli via the agar-well diffusion test. Here, the maximum
tested concentrations were employed (40%). Table 2 gives a first look on the antibacterial action of
the 20 selected EOs, which can be classified following the Rota et al. scale in weak if ZoI ≤ 12 mm,
moderate if ZoI ranged between >12 and <20 mm, and strong if ZoI ≥ 20 mm [23].
Table 2. Zones of inhibition (ZoI) of selected EOs against Gram-positive and Gram-negative bacteria
(n = 3, mean ± S.D.). The diameter of the holes (Ø = 6 mm) was included. Listing of antimicrobial
agents and respective results were done by descent order in respect to each bacterium. Ampicillin (A)





S. aureus E. coli
A 28.67 ± 0.58 A 23.50 ± 0.50
RO 18.33 ± 2.08 CJO 21.33 ± 0.58
FO 17.83 ± 0.76 TTO 14.67 ± 2.08
ELO 16.67 ± 1.15 SO 13.00 ± 2.65
NO 16.33 ± 1.53 CLO 12.83 ± 0.76
CJO 15.67 ± 1.53 NO 12.67 ± 1.15
CO 15.00 ± 1.00 CO 12.33 ± 1.58
SO 14.67 ± 0.58 RO 11.33 ± 3.21
PTO 13.50 ± 0.50 LGO 10.67 ± 0.58
TTO 13.33 ± 1.53 ELO 10.00 ± 1.00
CLO 12.67 ± 0.58 FO 9.83 ± 1.26
LGO 12.17 ± 0.29 LO 9.00 ± 1.00
PMO 11.33 ± 0.58 PMO 8.00 ± 0.50
LO 11.00 ± 1.00 OO 7.33 ± 0.58
GO 9.33 ± 0.58 GO 6.83 ± 0.29
CIO 9.17 ± 0.29 AO -
OO 8.83 ± 0.29 CIO -
AO 8.33 ± 0.58 HCO -
HCO - PTO -
SAO - SAO -
WO - WO -
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From all tested agents, ampicillin formed the strongest ZoI (Table S1). Ampicillin is a semi-synthetic
penicillin-like molecule that acquires its antimicrobial properties from the presence of a β-lactam ring
(four-membered cyclic amide) in its structure, which is known to affect the growth, viability, shape
division and integrity of bacterial cells. It is useful in the treatment of infections mediated by both
Gram-positive and Gram-negative bacteria [24]. Even though its antibacterial potential is well-known,
the results from Table 2 are not a statement of its superior antimicrobial contribution but are rather
associated with its ability to diffuse along the agar. The agar tortuosity may hinder the EOs diffusion,
particularly those with a superior viscosity and density (Table 1). As such, the results from Table 2 can
only be considered as indicatives of the antimicrobial potential of the agents and not of their intensity.
Still, when looking at both the S. aureus and E. coli data, it is possible to highlight the CJO, TTO, SO,
CLO, NO, and CO as the most probable to present a superior antimicrobial action as their ZoI falls
within the moderate activity range for both cases. Data also demonstrates the increased effectiveness
of the EOs against the Gram-positive bacterium compared to the Gram-negative. These results can be
explained by the differences in the cell wall structure of these bacteria, since the absence of an outer
cell membrane and periplasm in the Gram-positive bacteria allows higher molecules permeability,
while the Gram-negative are capable of restricting diffusion of hydrophobic molecules through its
lipopolysaccharide envelope reducing penetration [25,26]. From the group, the HCO, SAO, and WO
did not form any ZoI even though reports have been published on their antibacterial action [27–29].
This supports the premise established by Tavares et al. that the plant origin and the extraction methods
of natural products employed by each company may influence the properties of the final product [5].
3.2. MICs
MICs were established for each bacterium (Table 3), revealing the strongest and weakest
antimicrobial agents from the tested group. Apart from HCO, SAO, and WO, which results attest to
the absence of the ZoI (Table 2), all agents were found active against one and/or two microorganisms.
In the case of HCO, SAO, and WO a larger concentration than the maximum tested would be required.
Table 3. Minimal inhibitory concentrations (MICs) of selected EOs against Gram-positive and
Gram-negative bacteria (n = 3, S.D. < ± 5.0 µg/mL). Listing of antimicrobial agents and respective






S. aureus E. coli
CLO 0.82 CLO 0.82
CO 0.83 CO 0.83
CJO 22.38 CJO 11.19
TTO 22.38 TTO 11.39
A 0.03 A 0.03
ELO 36.63 SO 45.75
LGO 44.50 GO 89.50
NO 45.65 LGO 89.00
PTO 48.00 NO 91.30
CIO 88.20 ELO 146.50
LO 88.90 RO 180.02
RO 90.01 OO 342.40
SO 91.50 FO 342.80
OO 171.20 PMO 353.60
PMO 176.80 CIO >352.80
AO 191.40 LO >355.60
WO 236.40 HCO >374.00
GO 358.00 AO >382.80
FO >342.80 PTO >384.00
HCO >374.00 SAO >392.40
SAO >392.40 WO >472.80
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As anticipated, the ZoI results did not reflect the reality of the quantitative measurements.
Ampicillin was very effective against both bacteria, with an average MIC of ≈31.3 µg/mL; however,
between the EOs, the CLO, CO, CJO, and TTO were the most effective against the bacteria even though
their ZoI were not the largest (Table 2 and Table S1).
Data established the CLO, CO, and CJO as the most antibacterial from the EOs group, with
the last being closely followed by TTO. Both CJO and TTO belong to the Melaleuca genus, sharing
many identical components: CJO encompasses 1,8-cineole (42%), α-terpineole (18%), caryophyllene
(11%), limonene (4%), α-pinene (3%), and eugenol (1%) (v/v) [30], while TTO comprises terpinen-4-ol
(40%), γ-terpinene (20%), α-terpinene (10%), 1,8-cineole (5%), α-pinene (3%), and limonene (1%)
(v/v) [31]. Because of the similarities between CJO and TTO only one of the oils was selected for further
study. The TTO was excluded due to its relatively higher MIC. All of these components are known
to contribute significantly to the EOs antimicrobial activity. The differences in percentage between
the identical elements and the abundance of some components in detriment of others may explain
the small disparities in the MIC values; for instance, the presence of eugenol in the CJO. Eugenol
is characterized by a high antimicrobial action against a variety of microorganisms and ascribes its
activity to the presence of free hydroxyl groups capable of binding to proteins, this way preventing
enzyme action. Moreover, eugenol is also capable of disrupting the cytoplasmatic membrane increasing
the bacterial membrane nonspecific permeability and may affect the transport of ions and adenosine
triphosphate (ATP) [32]. The high eugenol content within the CLO and CO, ranging 80%, may also be
the reason for the reduced MIC values obtained, ≈0.8 mg/mL. Aside from eugenol, CLO also contains
β-caryophyllene (4%), benzyl benzoate (4%), cinnamaldehyde (3%), linalool (2%), and α-terpinene (1%)
(v/v) in its composition [33], while CO is also formed by eugenyl acetate (9%) and β-caryophyllene
(8%) [34]. These components have all also been reported in the literature as antimicrobial [35].
As observed in the results from Table 2, here too the differences in the cell wall structure of the
tested bacterial species may have hindered the EOs action against the Gram-negative bacteria. Indeed,
data (Table 3) confirms the enhanced antibacterial effect of many oils against S. aureus compared to E. coli.
From the group of the least effective EOs, the exceptions are the SO and the GO. This demonstrates the
potential of these two EOs in fighting infections caused by this Gram-negative bacterium.
3.3. Cell Wall Disruption
Considering the similarities between the EOs mechanisms of action against bacteria [5], only
the most effective, the CLO, was selected to examine the EOs interference in the cell membrane via
SEM. Figure 1 shows the morphology of the bacteria before and after contact with CLO at MIC. Before
contact, both bacteria exhibited a smooth, uninterrupted surface. S. aureus displayed a coccoid-shaped
conformation with grape-like arrangements being very frequent. On its turn, a rod-shaped architecture
was observed for E. coli, in which the formation of clusters was less common but proliferative signals
were evident. In both cases, observations were consistent with the literature [36,37].
EOs act primarily against the cell cytoplasmic membrane by accumulating at its surface and
disturbing its structure and functionality. This increases the membrane permeability and the probability
of intracellular content leakage, which ultimately leads to cell death [25]. In both bacteria, CLO was
capable of increasing the cell permeability, by distorting the membrane appearance and generating
holes or wrinkles. Deformed shapes followed by cell shrinkage and blebbing-like architectures were
observed in the S. aureus. Here too, leakage of cell content by cell membrane rupture was easily detected.
In the case of E. coli, it appears that the EO surrounded the cells, isolating them. As Gram-negative
bacteria are more resistant to hydrophobic biomolecules, to overcome their impermeability, EOs
rely on the organism’s isolation to slowly traverse through the outer wall porins [5,25]. In this
specific case, CLO may have relied on the abilities of its major component, eugenol, to affect the cells’
intracellular functions or ion transport [32] to progressively kill the bacterial cells without requiring
cell content leakage.
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Figure 1. Representative micrographs of S. aureus and E. coli bacteria morphology in the absence
(control, C) and presence of cinnamon leaf oil (CLO), at MIC value.
3.4. Wet-Spun Fibers Modification and Characterization
3.4.1. EO Loading Efficiency
The modification of the wet-spun fibers with the most effective essential oils (smaller MICs),
the CLO, CO, and CJO, was accomplished by adsorption via prolonged microfiber exposure (immersion),
under constant gentle orbital shaking. The immobilization period was set with ampicillin (positive
control) as absorbed biomolecule, in which absorbance measurements were conducted every 24 h of
incubation. Here, aliquots of the solution encasing the fibers were recovered and the amount adsorbed
by the fibers was determined by the differences in the absorbance between time 0 h and the chosen
periods for readings. This adsorption method was selected based on its simplicity and on the presence
of free hydroxyl groups (-OH) along the fiber’s surface, which, under prolonged exposure, could form
hydrogen bonds with some of the components present on the EOs structure. In this situation, this
adsorption mechanism could be further categorized as physisorption. By it, a quicker release of the
biomolecules under physiological conditions (desorption) could be attained [8].
Even though solutions were prepared at 2 x MIC, data were here calculated and presented as a
percentage of MIC. It was seen that after 72 h of contact, ≈ 106.37% of ampicillin was loaded onto
the fibers, which represented ≈33.24 µg/mL, an amount very similar to its MIC value. These results
established the maximum exposure time of the microfibers to all the remainder agents. Data reported
microfiber loading of ≈14.42% for CLO, which corresponded to ≈0.12 mg/mL, of ≈66.08% for CO or
≈0.55 mg/mL, and of ≈76.48% for CJO or ≈17.12 mg/mL. The differences in the adsorption values may
be explained by the location of their available functional groups for binding [38]. Even though many
of the CLO, CO, and CJO components are similar, their organization within the biomolecule chemical
structure may differ, facilitating or limiting intermolecular bonds with the CA/PCL.
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3.4.2. Morphology
Microfibers were processed by wet-spinning from a polymeric blend of CA/PCL. Processing
conditions were optimized so that the fiber production was continuous and uniform, despite using
a manual fiber collector. Figure 2a shows the resulting fiber morphology acquired by brightfield
microscopy. The overall homogeneity of the fibers was confirmed even though very small defects
(e.g., minor slope in the upper level of the ampicillin fiber), neglectable in light of the average size of
each sample (21 cm in length, with ≈0.5 mg in weight), were also observed. Beads or knots were not
detected. The fiber’s diameter distribution (Figure 2b) was calculated from 40 measurements made
along a group of microfibers treated in equal conditions. The average diameters ranged between 54 and
59 µm: with the control (F) at 53.9 ± 4.5 µm; ampicillin (FA) at 58.4 ± 8.0 µm; FCLO at 59.4 ± 5.0 µm;
FCO at 53.8 ± 5.9 µm; and FCJO at 56.3 ± 6.5 µm. Even though the control and the CO-treated samples
displayed the smallest diameters from the group, no significant differences were detected between
microfibers. This is to be expected since the amount of antimicrobial agent immobilized was very
reduced (Section 3.4.1). The behavior of CO compared to CLO or CJO may be explained by the affinity
of its components to the CA/PCL polymer blend. CO is composed of 80% eugenol and 9% eugenyl
acetate, which structure is very similar to eugenol [34,39]. Both possess free hydroxyl groups that may
become available to the polymeric blend for binding, promoting the formation of intricated bonds that
may turn the overall surface more hydrophobic, thus reducing the microfiber diameter. To date there
are no reports on the affinity of these components to the polymers in study; as such, further studies are
required to assess the validity of our premise.
Figure 2. (a) Images of the fiber’s morphology unloaded (control) and loaded with antimicrobial agents,
captured at 40x magnification using a brightfield microscope (scale bar = 30 µm). (b) Distribution of
fiber diameters before (C or control) and after the incorporation of the antimicrobial agents, ampicillin,
CLO, clove oil (CO), and cajeput oil (CJO). Data derive from measurements of 5 images collected at
10x magnification. There were no statistically significant differences between the unmodified and the
modified microfibers.
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3.4.3. Chemical Composition
Spectra of the CA/PCL microfibers, unmodified, and modified with ampicillin, CLO, CO, and CJO,
were collected (Figure 3). A small but wide adsorption peak at approximately 3400 cm−1 was observed
on all fibers. It corresponded to the stretching vibrations of intermolecular hydrogen bonds of the
-OH groups and may be associated with the exposure of the fibers to the air humidity. It may also be
allocated to the available –OH groups of CA that remained after contact with the EOs. The adsorption
peaks observed between 2950–2900 cm−1 corresponded to the stretching vibrations of the –CH of methyl
groups (–CH3) in CA and to the CH2 asymmetric stretching vibrations in PCL [14,40]. At 2865 cm−1,
another peak was detectable and was attributed to the symmetric CH2 stretching vibrations also in
PCL [40]. At 1735 cm−1, a very pronounced peak was detected; this was assigned to the carbonyl (C=O)
stretching vibrations and could be allocated to both CA and PCL. At 1370 cm−1 an important peak was
detected and assigned to –C–H symmetric deformation vibration of the acetate group in CA, and at
1293 cm−1 the C–O and C–C stretching vibrations associated with the crystalline phase of PCL were
detected [14,40]. Neither of these peaks is usually present on the other polymer, thus confirming their
homogenous blend. At 1240 cm−1, it was possible to identify the characteristic peak of –C–O–C, which
is related to asymmetric stretching vibrations of PCL and/or the CA ester group. The PCL symmetric
–C–O–C stretching vibrations were then detected at 1170 cm−1 [40]. The presence of CA within the
blend was also detected by the band between 1090 and 1000 cm−1 which was associated with the
stretching modes of –C–O single bonds, and the absorption peak at 904 cm−1 which may be due to the
combination of the –C–O stretching with the -CH2 rocking vibrations [14]. Because of the overlapping
of bands between CA and PCL, analogous spectra predominated, and was very difficult to determine
the specific contribution of each polymer. Still, the presence of the two polymers was confirmed.
Figure 3. ATR-FTIR spectra of the cellulose acetate (CA)/polycaprolactone (PCL) microfibers unmodified
(F) and modified with ampicillin, CLO, CO, and CJO (4000–400 cm−1). As the most significant for
this study, the section between 1700–1300 cm−1 was amplified for a clearer detection of the peak’s
characteristic of the immobilized biomolecules.
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Regarding the modification of the fibers with the antimicrobial agents, the most important
observations were made at the absorption peaks of 1577, 1543, and 1452 cm−1. Even though small,
these were not present on the unmodified microfibers. The peaks at 1577 and 1543 cm−1 have been
assigned to the aromatic ring C=C skeleton vibration of an aromatic substance. Here, even though the
1577 cm−1 is the most commonly found and noticeable in many reports, there have been those that
demonstrate the presence of second peaks or even shifts detectable at smaller wavenumbers, including
at 1543 cm−1 [41]. It may also be explained by the possible interactions made with the polymers CA and
PCL by means of hydrogen bonding [42]. These peaks were also identified in the ampicillin-modified
fibers and were attributed to inplane vibrations of the –CH groups [δCH(ph)] and to the stretching
vibration of the –C–C groups, respectively [43]. At 1452 cm−1, the characteristic peak of the –C–OH
absorption bending vibration from the alcohol moieties of the EOs was detected. This peak has been
identified in all the tested EOs [44–46]. The collected data is proof of the presence of the antimicrobial
agents within the microfibers and, therefore, attests to their successful immobilization.
3.4.4. Thermal Stability
Degradation steps associated with temperature rise were recognized on the CA/PCL fibers via
TGA and DTG (Figure 4). The first degradation step was identified at approximately 150 ◦C for the
control samples (F) and between 220 and 240 ◦C for the remainder biomolecules. This indicates that
the volatile nature of the EOs can be protected by being combined with polymeric matrices. Wen et al.
reported just that by observing a shift in the first degradation step from ≈70 ◦C to ≈120 ◦C, when
combining cinnamon oils with poly(vinyl alcohol) nanofilms [47]. Moreover, because of the reduced
amount of EOs immobilized, the interactions established with the polymeric fibers may have left fewer
free groups available, increasing the biomolecules’ stability and, consequently, their thermal resistance.
This may also explain the differences in temperatures necessary to induce the first degradation step
between the control samples (F) and the EO-treated samples. The incorporation of phenolic compounds
(e.g., eugenol) within polymeric matrices has been reported to have a plasticizing effect that may shift
the temperatures of degradation to higher levels [48]. This was particularly noticeable in the FCLO and
FCJO. In the case of FCO, the relatively smaller diameters attained after modification (Section 3.4.2),
which may have resulted from different intermolecular bonding, may also have narrowed the fiber’s
thermal resistance.
From the first degradation step until the second at ≈360 ◦C, all samples started behaving similarly.
At this point, the antimicrobial agent’s influence was neglectable. The degradation steps were then
associated with the depolymerization of the CA polymeric chains, as the absorbed energy activated
the undoing of the glycosidic linkages producing glucose, and to the cleavage of the PCL polymeric
backbone, which initiates with the degradation of the side chains and progresses to the main chain
scission [13,14,49]. The progression from the first to the second degradation steps was very smooth
and gradual and represented a total mass loss of ≈88%. Interestingly, the addition of PCL to the
CA polymeric solution raised the characteristic second degradation peak from ≈340 ◦C to ≈360 ◦C,
thus confirming the homogeneity of the polymeric blend and the increased thermal resistance of the
CA-based fibers. From 400 to 600 ◦C, the continuing weight loss is ascribed to further degradation of
the polymers into carbon char.
3.5. Time-Kill Kinetics
The kill-time kinetics for each antimicrobial agent and loaded microfiber was determined by the
number of remaining viable cells at specific incubation periods, 1, 2, 4, 6, and 24 h (Figure 5) and the
associated log reduction (Figure 6). Data were compiled so the exposure/action time and the overall
potency of the antibiotic and the EOs were established against both Gram-positive and Gram-negative
bacteria free from antimicrobial agents or loaded fibers. For most of the free biomolecules, bacterial
reduction was observed from the very first moments of contact. Indeed, after 2 h of incubation, ≈0.87 to
≈1.20 log reduction was verified against S. aureus and ≈0.97 to ≈2.48 log for E. coli, which represented
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an average decrease of ≈90% and ≈97% in the total number of viable cells, respectively. The continuous
and progressive reduction in the number of viable bacteria and an increase in the log reduction values
demonstrated the free agents’ effectiveness throughout time. Yet, there were no verifiable susceptibility
patterns for each bacterium. For instance, CJO, which was present at the highest concentration, did
not exert the quickest effect on the bacteria; in fact, in the first moments of interaction, CJO allowed
S. aureus to grow. This inability to predict the behavior of an EO by its working concentration has been
previously reported [5]. The only exception was CLO. Its bacterial response was the slowest from
the group, which was proportional to the concentration in test. Regardless, after 24 h of incubation,
bacteria treated with CLO experienced a reduction levels of ≈3.65 log for S. aureus and ≈3.55 log for
E. coli, which were quite close to those registered by the other EOs. CLO may rely on the properties
of its major component, eugenol, to affect the cells’ intracellular functions or ion transport, this way
preventing important metabolites in the bacteria from working at full capacity and, ultimately, leading
to the cell death [32]. Similar observations were made on the modified microfibers. Once again, FCLO
displayed the lowest reduction levels, allowing bacteria to grow in the first 6 h. After that point, its
action became more effective. It is likely that the intermolecular bonds generated during the 72 h
immobilization period required more time to break, and consequently to allow the release of the EOs.
The same growing patterns were observed for the other agents. However, their effectiveness in killing
bacteria was superior to that of FCLO (Figure 6), as expected. There is yet to be a consensus on the
period at which EOs are the most effective. However, it is generally accepted that they stimulate cell
autolysis in exponential and stationary cell phases [50]. Our findings demonstrated that exponentially
growing cells are very susceptible to the EOs’ action when in a free state, and that when immobilized
their action tends to occur in a more stationary stage. Undeniably, log reduction was most significant
after 24 h of culture. At this point, it was evident that S. aureus was more susceptible to the prolonged
action of the EOs than the E. coli, the only exception being the CJO which was seen to act more
effectively against the Gram-negative bacteria (Table 3).
Figure 4. Cont.
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Figure 4. (a) TGA and (b) DTG curves of the CA/PCL microfibers, unloaded (F) and loaded with
antimicrobial agents, obtained from 25 to 600 ◦C under nitrogen atmosphere, flow rate of 200 mL/min
and temperature rise of 10 ◦C/min.
Figure 5. Killing-time curves of (a,c) free antimicrobial agents at microfiber loading concentration and
(b,d) unloaded and loaded microfibers, against S. aureus and E. coli bacteria, up to 24 h of culture.
Data derived from three repetitions. Positive controls for each bacterium (growth without agent or
microfiber) were also conducted, reaching maximum values of ≈1.8 × 107 and ≈2.1 × 107 CFUs/mL for
S. aureus agent-free solution and fiber-containing solution, respectively, and of ≈1.5 × 107 and ≈1.1 × 107
CFUs/mL for E. coli agent-free solution and fiber-containing solution, respectively, after 24 h culture
(data not shown in graphic).
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Figure 6. (a) S. aureus and (b) E. coli reduction (calculated as log reduction) in relation to control samples,
namely bacterial inoculum without antimicrobial agents and unloaded fibers (n = 3, mean ± S.D.).
The elimination of 100% of bacteria was considered as log 5.
3.6. Cell Membrane Permeability
The effect of the EOs on the Gram-positive and Gram-negative cell membrane permeability was
evaluated through the percentage of REC (Table 4), after 6 h of incubation. Data reported an increase
in the solution’s conductivity upon incubation with the antimicrobial agents, which indicated the
cell membranes became permeable, at different levels, after treatment with the free biomolecules or
the loaded fibers. This was particularly noticeable on the S. aureus bacteria suggesting the release of
electrolytes from within the cells by cellular leakage. Indeed, the lysis and death of the bacteria by
the action of ampicillin or the EOs may have lead the bacteria to release the intracellular content and
with electrolytes such as K+, Ca2+, and Na+ capable of raising the conductivity of the solution [51].
Considering the EOs primary mechanism of action against bacteria resorts to the accumulation of
biomolecules at their surface, disturbing its structure and functionality, it is likely the content leakage
to be the result of their interaction with the cytoplasmic membrane [25]. The cytoplasmic membrane
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works as a permeability block for ions that are crucial to the cell membrane functions, namely, to
maintain enzyme activity and to sustain the normal cell metabolism. Thus, regulation of ion hemostasis
is of great importance to maintain the energy status of the cell. Even small variations in the membrane
structure can hurtfully affect cell metabolism and lead to cell lysis [52]. This data is consistent with
the SEM observations made in Figure 1, in which intracellular content release by CLO action was
particularly noticeable on S. aureus. Overall, S. aureus showed higher electric conductivity than E. coli
bacteria, which is in agreement with previous reports [53]. Finally, it is important to highlight the
significant effect of CLO on the bacteria membrane permeability, even at ≈14% of its MIC value. These
results demonstrate the potent action of this agent and its potential for biomedical applications.
Table 4. Effect of the antimicrobial agents in free state and loaded onto CA/PCL microfibers, in the cell
membrane permeability of S. aureus and E. coli bacteria (n = 3, S.D. < ±0.5%). Solutions containing the
free agents were prepared at concentrations equal to those of microfiber loading. The bacteria inoculum
without any agent (C) and the unloaded fibers (F) were used as control.
REC (%)
Bacteria C A CLO CO CJO F FA FCLO FCO FCJO
S. aureus −0.49 19.10 9.81 19.83 20.41 −0.29 1.96 1.10 3.19 8.34
E. coli −1.01 15.50 6.08 12.69 25.09 −1.32 0.75 0.67 1.69 4.49
4. Conclusions
The antibacterial spectrum of activity of 20 EOs was analyzed in this work. Data reported the
CLO, CO, and CJO oils as the most effective against the Gram-positive bacteria S. aureus and the
Gram-negative bacteria E. coli. These EOs were further characterized and, then, immobilized onto
CA/PCL microfibers produced via wet-spinning. Fibers displayed a uniform and homogeneous
morphology with little variations in diameter being detected upon agent immobilization. FTIR and
TGA data confirmed the successful fiber modification by detecting characteristic peaks of the EOs and
by demonstrating the increased overall thermal stability of the polymeric blend, respectively. Even at
small amounts, below MIC value, the EO-modified microfibers promoted cell death compared to the
control groups (unloaded and ampicillin-modified fibers), by disrupting and permeabilizing the cell
cytoplasmic membrane. Considering only ≈14% of the MIC value of CLO were immobilized onto the
CA/PCL microfibers and the antimicrobial activity promoted from that, these were regarded as the
most effective. Data demonstrated the potential of CA/PCL wet-spun microfibers loaded with EOs for
applications in biomedicine, in which the treatment of infections is the main target. However, it should
be noticed that these tests are only preliminary work, a proof-of-concept of the feasibility of adsorbing
EOs onto CA/PCL wet-spun microfibers capable of being released in physiological conditions and
subsequently promote bactericidal action should be attained. Future studies are required to further
explore new strategies for adequate loading amount in smaller time frames, to evaluate the mechanisms
of action of the immobilized agents in detail, and their effectiveness towards selected bacterium species
in prolonged exposure periods, so that antibiotic replacement can be envisioned.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/10/8/1129/s1,
Figure S1: Schematic representation of the employed wet-spinning apparatus, Table S1: ZoI of selected EOs against
Gram-positive and Gram-negative bacteria. Images were collected without regard for size proportionality, being
only used as representations of the halos formed. Listing of antimicrobial agents was organized by alphabetical
order. Ampicillin (A) was used as positive control agent.
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